GlassScriptPhysician profile
Viral Patel
NPI 1942691209
$3,914.17
in general payments reported to CMS, 2019-2025
35 companies · $79.55 in 2025
The $79.55 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $461 · 2021: $985 · 2022: $903 · 2023: $646 · 2025: $79.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $746.81 | 2019-2023 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $558.87 | 2019-2023 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Actelion Pharmaceuticals US, INC. | $469.58 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $245.55 | 2019-2022 | |
| Genentech USA, INC. | $178.50 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $172.58 | 2019-2023 | Dupixent |
| Electromed, INC. | $130.47 | 2019-2023 | Smartvest |
| Mylan Specialty L.P. | $125.04 | 2019-2023 | Yupelri |
| Pulmonx Corporation | $113.85 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Mallinckrodt Hospital Products INC. | $111.45 | 2021-2022 | |
| Phadia US INC. | $106.61 | 2019 | |
| United Therapeutics Corporation | $75.78 | 2019-2022 | |
| Genzyme Corporation | $75.75 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $71.61 | 2019-2023 | |
| Inogen, INC. | $64.89 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.14 | 2025 | Lifevest |
| Philips North America LLC | $57.20 | 2019-2023 | |
| Organogenesis INC. | $55.38 | 2023 | Puraply |
| Takeda Pharmaceuticals U.S.A., INC. | $54.13 | 2023 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $49.45 | 2020-2022 | |
| Harmony Biosciences LLC | $48.50 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $43.32 | 2021-2022 | |
| Grifols USA, LLC | $40.60 | 2021 | |
| Allergan, INC. | $37.70 | 2019 | |
| Ethicon INC. | $36.04 | 2019 | |
| Insmed, INC. | $32.22 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $24.93 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.47 | 2021 | |
| Inspire Medical Systems, INC. | $20.41 | 2025 | Inspire |
| Jazz Pharmaceuticals INC. | $18.10 | 2021 | |
| Merck Sharp & Dohme LLC | $16.20 | 2023 | Belsomra |
| Shire North American Group INC | $14.88 | 2019 | |
| Advanced Respiratory, INC | $13.19 | 2021 | |
| Circassia INC. | $12.60 | 2019 | |
| Mallinckrodt Enterprises LLC | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viral Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.